Company Overview
About Advil
Advil is a global over-the-counter ibuprofen pain relief brand — owned by Haleon plc (LSE: HLN / NYSE: HLN), the consumer healthcare company spun off from GSK on July 18, 2022, with Pfizer completing its full stake exit in early 2025 for $3+ billion — providing consumers with 23+ ibuprofen-based product varieties for pain, headache, cold, and sleep management including Advil Extra Strength, Advil Rapid Release Gels, Advil PM, Advil Dual Action (ibuprofen + acetaminophen), and Children's Advil. Advil entered the US market in 1984 (the first OTC ibuprofen in America, considered the "most famous prescription-to-OTC switch in history") and generates approximately $800 million+ annually as one of Haleon's flagship brands alongside Sensodyne, Panadol, Centrum, and Theraflu. In September 2024, Advil Dual Action became the first OTC pain reliever to earn the American Dental Association (ADA) Seal of Acceptance for temporary management of acute dental pain.
Business Model & Competitive Advantage
Advil's ibuprofen formulation addresses the inflammation-driven pain and fever that makes it the preferred OTC analgesic for musculoskeletal pain, dental pain, menstrual cramps, and fever: ibuprofen's mechanism of action (inhibiting prostaglandin synthesis via COX-1 and COX-2 inhibition) addresses the inflammation component of pain more effectively than acetaminophen for conditions with an inflammatory etiology — making Advil the recommended OTC option for arthritis, muscle injury, headache with tension component, and post-procedure dental pain where inflammation drives the symptom. Advil Dual Action's combination (ibuprofen + acetaminophen) provides complementary pain pathways coverage that clinical studies demonstrate superior efficacy to either agent alone — the mechanism behind the ADA Seal for dental pain management.
Competitive Landscape 2025–2026
In 2025, Advil (Haleon) competes in the OTC analgesic, ibuprofen pain relief, and consumer healthcare market with Tylenol (Kenvue/Kimberly-Clark pending, acetaminophen #1 recommendation), Aleve (Bayer, naproxen sodium), and Motrin IB (Johnson & Johnson/Kenvue) for pharmacist recommendation, retail shelf positioning, and consumer OTC pain relief purchasing. Haleon's standalone strategy (post-GSK spinoff and post-Pfizer exit) focuses Advil investment on brand building, formulation innovation, and international market expansion — without the capital allocation competition from GSK's pharmaceutical pipeline or Pfizer's priorities. The ADA Seal for dental pain (a first in the OTC category) provides a differentiated clinical claim for the dental pain management segment. The 2025 strategy under Haleon CEO Brian McNamara focuses on digital health integration (Advil companion apps for pain tracking), growing Advil PM and Advil Dual Action penetration, and defending shelf position against private label ibuprofen share gains at major retailers.
The Advil Story
Founders
Company Timeline
Major milestones in Advil's journey
Leadership Team
Meet the leaders behind Advil
Brian McNamara
Brian McNamara serves as CEO of Haleon, the parent company of Advil. He leads the global consumer healthcare company spun off from GSK in 2022, managing brands including Advil, Sensodyne, and Centrum.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Advil is an emerging player bringing innovative solutions to the Healthcare market.
Enterprise Scale
With $3000M in revenue, Advil operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Chick-fil-A
Chick-fil-A is the largest US quick-service chicken restaurant chain, generating over $22 billion in annual system-wide sales from approximately 3,000 locations — more revenue per restaurant than any
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
Hey Telo
Hey Telo is a Berlin-based AI voice agent company building phone-answering and administrative automation specifically for Germany's 1 million+ independent craftsman businesses (Handwerksbetriebe) — HV
H&M (Hennes & Mauritz)
H&M Hennes & Mauritz is a Swedish multinational fashion retailer founded in 1947, operating brands including H&M, COS, & Other Stories, ARKET, and Weekday. The company runs approximately 4,100 stores
Compare Advil with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Advil? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Advil Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Advil vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →